Head and Neck Cancer

  • Shushan Rana
  • John M. HollandEmail author
  • Kristina H. Young
  • Celine Bicquart Ord


Head and neck cancer accounts for more than 50,000 cancer cases per year in the United States. The remarkable anatomic complexity within a small geometric confine warrants considerable attention to disease delineation and organs at risk. This section provides a comprehensive overview of head and neck subsites, including clinicopathologic spread in relation to anatomical structures and multimodality management. This section has been expanded to include updates in clinical staging as introduced by the American Joint Committee on Cancer, management of HPV-positive oropharynx cancer, approaches to cervical node management, and new information on systemic regimens in the setting of concurrent or sequential chemoradiation.


Pharynx HPV Cetuximab Cervical nodes Cisplatin 

Copyright information

© Springer Nature Switzerland AG 2021

Authors and Affiliations

  • Shushan Rana
    • 1
  • John M. Holland
    • 2
    Email author
  • Kristina H. Young
    • 3
  • Celine Bicquart Ord
    • 4
  1. 1.Radiation OncologistPeaceHealth Southwest Medical CenterVancouverUSA
  2. 2.Department of Radiation MedicineOregon Health Science UniversityPortlandUSA
  3. 3.The Oregon Clinic – Radiation OncologyPortlandUSA
  4. 4.Carson Tahoe Radiation Oncology AssociatesCarson CityUSA

Personalised recommendations